News & Discoveries

March 22, 2021

Scientists at UCSF’s Neuroscape brain research center have developed a first-of-its-kind virtual reality video game that can improve memory in healthy, older adults.

March 22, 2021

Cells Called Astrocytes Can Independently Promote Longer or Deeper Sleep in Mice, a New Study ShowsResearchers at UCSF have confirmed that a different, long under-studied type of brain cell – astrocytes, named for their star-like shape – can influence how long and how deeply animals sleep.

March 17, 2021

Obesity, Hypertension, High Glucose in Early Adulthood May Take Heavy Toll on Cognition in Late Life, UCSF-Led Study ShowsA new study led by UC San Francisco finds that young adulthood may be the most critical period to practice the healthy lifestyle habits that may protect the brain from cognitive decline decades later.

February 25, 2021

UCSF and UC Berkeley today announced a long-term research partnership with Genentech, a member of the Roche Group, and its parent company, Roche Holding AG, to speed the development of new therapeutics for debilitating brain diseases and disorders of the central nervous system.

February 19, 2021

Protein Complex Shifts DNA Shape to Let Progenitor Cells Become Neurons In a new study, UCSF and Stanford researchers have identified a central switch that appears to control when neural progenitor cells stop multiplying and start differentiating into mature neurons.

February 10, 2021

The new Institute will bring together scientists and clinicians from all UCSF sites to address the most critical questions related to the science of aging.

February 05, 2021

Powerful Frog-Embryo Model Unveils New Role for Risk Genes, Protective Effect of Estrogen A new study of autism risk genes by UCSF and UC Berkeley scientists implicates disruption in prenatal neurogenesis – a process in which specialized “progenitor” cells give rise to new brain cells – in the development of autism spectrum disorders.

January 18, 2021

Case Study Shows Promising Proof of Concept for Ongoing Clinical Trial Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.

January 11, 2021

Findings Could Lead to Targeted Treatments to Boost Brain’s Resilience A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.

December 21, 2020

UCSF Psychologist Says ‘Brain Health’ Factors, Not Lower Benchmarks for Blacks, Should Be Used in Cognitive TestingA UCSF clinical psychologist has taken aim at the NFL for “race-norming” Black players diagnosed with dementia, a practice that is depriving them of the monetary awards allocated to former footballers with neurodegenerative disorders.

Pages